NeuroScience Flashcards

1
Q

Vyvgart: generic name?

A

Efgartigimod alfa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Efgartigimod: brand name?

A

Vyvgart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vyvgart: indication?

A

Seropositive (acetylcholine-receptor antibody-positive) generalized myasthenia gravis (gMG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Vyvgart: conditions for NHB?

A

After treatment failure with both IVIG and rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vyvgart: conditions for private insurance?

A

After treatment failure with either IVIG or rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Vyvgart: mechanism of action?

A

Neonatal Fc receptor (FcRN) blocker, thus reducing total level of IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Vyvgart: how is it administered?

A

IV, once weekly for 4 weeks. May repeat cycles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Vyvgart: partner?

A

Argenx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Spinraza: generic name?

A

Nusinersen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nusinersen: brand name?

A

Spinraza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Spinraza: partner?

A

Biogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spinraza: indication(s)?

A

Spinal Muscular Atrophy (SMA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Spinraza: mechanism of action?

A

Antisense Oligonucleotide (ASO) that increases production of SMN2, thus compensating for the mutated SMN1 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Kyprolis: generic name?

A

Carfilzomib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carfilzomib: brand name?

A

Kyprolis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Kyprolis: indication(s)?

A

Relapsed or refractory multiple myeloma, in patients who’ve received previous treatments.
Kyprolis is given in combination with other treatments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Kyprolis: partner?

A

Amgen

18
Q

Kyprolis: mechanism of action?

A

Proteasome inhibitor. As a result, protein is accumulated in the myeloma cell and the cell dies.

19
Q

Uplizna: generic name?

A

Inebilizumab

20
Q

Inebilizumab: brand name?

A

Uplizna

21
Q

Uplizna: indication(s)?

A

Aquaporin-4-IgG+ Neuromyelitis Optica Spectrum Disorder (NMOSD)

22
Q

Uplizna: partner?

A

Amgen

23
Q

Zurzuvae: generic name?

A

Zuranolone

24
Q

Zuranolone: brand name?

A

Zurzuvae

25
Q

Zuranolone: indication(s)

A

Post-partum depression

26
Q

Zuranolone: partner?

A

Biogen

27
Q

Zuranolone: administration?

A

PO, 50 mg once daily for 14 days

28
Q

Zuranolone: mechanism of action?

A

GABA-A receptor positive allosteric modulator (PAM), enhancing signalling through the receptor

29
Q

Voxzogo: generic name?

A

Vosoritide

30
Q

Vosoritide: Brand name?

A

Voxzogo

31
Q

Voxzogo: partner?

A

BioMarin

32
Q

Voxzogo: Indication(s)?

A

Achondroplasia and open growth plates

33
Q

Voxzogo: Administration?

A

Daily S/C injection

34
Q

Voxzogo: Adverse effect(s)?

A

Decrease in blood pressure

35
Q

Voxzogo: mechanism of action?

A

In achondroplasia, bone growth is inhibited due to a mutation in Fibroblast Growth Factor Receptor 3 (FGFR3).
Vosorotide antagonizes downstream signalling in the receptor’s signal pathway and promotes chondrocytes proliferation and differentiation.

36
Q

Uplizna (Inebilizumab): Administration?

A

Initial: Two IV infusions over 2 weeks
Maintenance: every 6 months

37
Q

Daybue: generic name?

A

Trofinetide

38
Q

Trofinetide: brand name?

A

Daybue

39
Q

Daybue: indication(s)?

A

Rett syndrome

40
Q

Daybue: administration

A

PO

41
Q

Daybue: partner?

A

Acadia